Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David H. Ebb, M.D.

Co-Author

This page shows the publications co-authored by David Ebb and Nancy Tarbell.
Connection Strength

1.546
  1. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar; 17(3):287-298.
    View in: PubMed
    Score: 0.167
  2. A phase II trial of proton radiotherapy for medulloblastoma: Preliminary results. J Clin Oncol. 2010 Jun 20; 28(18_suppl):CRA9507.
    View in: PubMed
    Score: 0.113
  3. Proton radiotherapy for Hodgkin's disease in the sacrum. Lancet Oncol. 2005 Jul; 6(7):532-3.
    View in: PubMed
    Score: 0.080
  4. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma. Cancer. 2021 Oct 15; 127(20):3840-3846.
    View in: PubMed
    Score: 0.061
  5. Clinical outcomes of pediatric patients with autism spectrum disorder and other neurodevelopmental disorders and intracranial germ cell tumors. Pediatr Blood Cancer. 2021 Aug; 68(8):e28935.
    View in: PubMed
    Score: 0.059
  6. Proton Radiation Therapy for Pediatric Craniopharyngioma. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1480-1487.
    View in: PubMed
    Score: 0.059
  7. Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1044-1052.
    View in: PubMed
    Score: 0.059
  8. Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy. Neuro Oncol. 2021 01 30; 23(1):156-166.
    View in: PubMed
    Score: 0.059
  9. Long-term health-related quality of life in pediatric brain tumor survivors receiving proton radiotherapy at <4 years of age. Neuro Oncol. 2020 09 29; 22(9):1379-1387.
    View in: PubMed
    Score: 0.058
  10. Increased distance from a treating proton center is associated with diminished ability to follow patients enrolled on a multicenter radiation oncology registry. Radiother Oncol. 2019 05; 134:25-29.
    View in: PubMed
    Score: 0.051
  11. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
    View in: PubMed
    Score: 0.050
  12. Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up. Cancer. 2018 08; 124(16):3390-3400.
    View in: PubMed
    Score: 0.049
  13. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors. Cancer. 2018 05 15; 124(10):2238-2245.
    View in: PubMed
    Score: 0.048
  14. Case 32-2016. A 20-Year-Old Man with Gynecomastia. N Engl J Med. 2016 10 20; 375(16):1567-1579.
    View in: PubMed
    Score: 0.044
  15. Proton beam therapy for medulloblastoma - Author's reply. Lancet Oncol. 2016 05; 17(5):e174-5.
    View in: PubMed
    Score: 0.042
  16. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016 06; 18(6):881-7.
    View in: PubMed
    Score: 0.041
  17. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):287-296.
    View in: PubMed
    Score: 0.041
  18. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):133-138.
    View in: PubMed
    Score: 0.041
  19. Use of proton therapy for re-irradiation in pediatric intracranial ependymoma. Radiother Oncol. 2015 Aug; 116(2):301-8.
    View in: PubMed
    Score: 0.040
  20. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):358-67.
    View in: PubMed
    Score: 0.039
  21. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8.
    View in: PubMed
    Score: 0.039
  22. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. Radiother Oncol. 2014 Oct; 113(1):89-94.
    View in: PubMed
    Score: 0.038
  23. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1060-1068.
    View in: PubMed
    Score: 0.037
  24. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013 Nov; 15(11):1552-9.
    View in: PubMed
    Score: 0.035
  25. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):120-6.
    View in: PubMed
    Score: 0.035
  26. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications. Neuro Oncol. 2013 Jul; 15(7):955-60.
    View in: PubMed
    Score: 0.034
  27. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):114-20.
    View in: PubMed
    Score: 0.034
  28. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol. 2012 Jun 10; 30(17):2079-86.
    View in: PubMed
    Score: 0.032
  29. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1142-8.
    View in: PubMed
    Score: 0.031
  30. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):121-9.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.